Remove category opinion
article thumbnail

Pharmapack Europe Awards 2023 winners announced

European Pharmaceutical Review

Three categories were available for entry in the Exhibitor Innovations section. The product awarded in the patient-centric design category provides accurate and reliable drug delivery of therapeutic and prophylactic medicinal substances, by intradermal injection. It provides an equal barrier to a traditional aluminium lid or PVC.

article thumbnail

Data-Led Digital KOL Engagement

pharmaphorum

When creating engagement plans for individual Digital Key Opinion Leaders (DOLs), it’s best to look at a range of data-led metrics about each DOL to fine tune the engagement and maximise benefit for all parties. data multiplier, content creator, opinion former, proactive educator, etc.), A plethora of such phenotypes are possible (e.g.

105
105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

JB Pharma launches knowledge based app for doctors

Express Pharma

Key highlights of the app include sessions from practicing national and international Key Opinion Leaders (KOLs) who will share their subject expertise and provide valuable insights to foster medical know-how. The post JB Pharma launches knowledge based app for doctors appeared first on Express Pharma.

article thumbnail

Delivering strategic realignment through War Games

Fuld & Company Blog

Outcome The war game resulted in six key recommendations, leading the company to: Develop strategies to focus on industry partnerships Re-align current product positioning Launch a new product range Re-focus their category management to leverage trade relationships and counter the competitive threat posed by the competitor.

52
article thumbnail

Expert Insights

Pharma and Life Sciences Blog

From cutting-edge trends and best practices in procurement optimization to supply chain risk management and sustainability initiatives, GEP has curated a selection of insights and expert opinions to empower you in navigating the dynamic landscape of procurement and supply chain management. Subscribe to our Knowledge Bank for more.

52
article thumbnail

CHMP backs Amicus’ therapy for Pompe disease

pharmaphorum

Amicus Therapeutics could be just weeks away from getting EU approval for its new Pompe disease therapy Pombiliti after getting a positive opinion on the drug from the EMA’s human medicines committee. Sanofi makes more than $1 billion a year from its Pompe disease franchise.

98
article thumbnail

Latest CMS Data Reveal the Truth About U.S. Drug Spending

Drug Channels

I examine the growth rates of major spending categories, break down costs vs. utilization, and highlight the unfavorable out-of-pocket dynamics for prescription drugs compared with hospital care. Regular readers know the unofficial motto of Drug Channels : "Everyone is entitled to their own opinion, but not their own facts."